Krishna Institute of Medical Sciences Limited board approved the acquisition of up to 51% equity stake in Insignia Healthcare Private Limited on October 6, 2026. The move aims to secure operational control over a hospital facility currently managed by KIMS under an Operations and Maintenance agreement.

The target entity, Insignia Healthcare Private Limited, operates a 150-bed hospital in Guntur, Andhra Pradesh, with potential capacity expansion to 200 beds. KIMS is already engaged as the exclusive manager and operator of this facility, providing medical services through its infrastructure and clinical team.

Acquisition Details and Valuation

The acquisition will be executed via a creeping acquisition method over an indicative period of 12 to 24 months. The consideration structure is entirely cash-based. Initial shares will be acquired at ₹30.35 per equity share, based on a valuation report by BDO Valuation Advisory LLP dated October 5, 2026. Subsequent acquisitions will be priced based on independent valuations at the time of purchase.

Financial Profile of Target Entity

Insignia Healthcare has shown significant revenue growth since its incorporation in July 2018. The entity reported a turnover of ₹104.5 crore in FY25, a substantial jump from ₹0.09 crore in FY24. However, the company remains loss-making, reporting a Profit After Tax (PAT) of -₹13.28 crore for FY25 against a net worth of ₹243.3 crore.

What the Numbers Show

A notable divergence exists between Insignia’s rapid top-line expansion and its bottom-line performance. While turnover surged from negligible levels in FY24 to ₹104.5 crore in FY25, the entity posted a loss of ₹13.28 crore. This suggests that despite achieving significant operational scale, the hospital’s cost structure or initial setup expenses continue to outweigh revenue generation. The acquisition allows KIMS to consolidate these losses into its balance sheet while gaining full control over the asset base, which includes substantial fixed assets reflected in the ₹243.3 crore net worth.

Krishna Institute of Medical Sciences Limited has approved the acquisition of up to 22% equity stake in Splendid Hospitals Private Limited (Kompally) for an aggregate consideration of up to ₹40 crore. The investment will be made through primary infusion, marking a strategic move by the hospital operator to deepen its presence in the Hyderabad healthcare market.

The board decision was taken at a meeting held on October 6, 2026. KIMS currently serves as the Operations and Maintenance (O&M) partner for the target entity. The company stated that the acquisition is intended as a strategic investment to leverage the existing operational relationship.

Target Entity Financials

Splendid Hospitals Private Limited, incorporated in September 2022, operates a facility in Kompally, Telangana. The hospital is equipped with modern medical infrastructure and has the potential to expand its capacity to over 225 beds. Despite the expansion potential, the entity remains in the early stages of revenue generation and profitability.

Note: FY26 figures represent the fiscal year ending March 2026.

Deal Structure and Terms

The acquisition involves the purchase of equity shares with a face value of ₹10 each. The price is determined based on a valuation report issued by BDO Valuation Advisory LLP on October 5, 2026. Key terms of the transaction include:

• Consideration: Cash payment up to ₹40 crore.
• Stake Acquired: Up to 22% equity shareholding.
• Method: Primary infusion into the target entity.
• Completion Timeline: On or before March 31, 2027.
• Regulatory Status: No governmental or regulatory approvals are required for this specific transaction.

What the Numbers Show

A divergence exists between the target's asset base and its income statement performance. While Splendid Hospitals reports a net worth of ₹38.69 crore, it recorded a net loss of ₹8.92 crore in FY26 against a turnover of just ₹1.39 crore. This indicates that the valuation is likely driven by the underlying real estate assets and infrastructure potential rather than current cash flows. The rapid increase in turnover from ₹0.30 crore in FY25 to ₹1.39 crore in FY26 suggests the hospital is in a ramp-up phase, yet the significant operating losses highlight the capital-intensive nature of scaling operations in the healthcare sector.